Expression Levels of PF4, ALOX12, ITGA2B, F131A in Pregnant COVID-19 Survivors

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2024 Nov 14

PMID 39543003

Authors

Mai M Shaker

Asia E Abdelghany

Nesma M Elaraby

Affiliations

Soon will be listed here.

Abstract

COVID-19 is viral illness caused by SARS-CoV-2. The immediate complications of COVID-19 are well defined and associated with increased mortality. A global effort is required to determine its effects on implantation, fetal growth and labor. Post COVID-19 recovery period presents a further challenge regarding service provision, prevention, and management. To assess the expression of Platelet Factor 4 (PF4), Arachidonate 12-lipoxygenase (ALOX 12), Integrin alpha-IIb (ITGA2B) & Coagulation Factor XIII A Chain F13A1 in post-acute COVID-19 survivors pregnant women. Prospective case control study, conducted on 400 pregnant women. Case group consists of 200 singleton pregnancies who had recovered from COVID-19 since 4-6 weeks before conception. Control group consists of 200 singleton pregnancies with no history for COVID-19. Expression levels of ALOX12, PF4, ITGA2B, and F13A1genes were determined using quantitative reverse transcription polymerase chain reaction method (qRT-PCR). Expression levels of ALOX12, ITGA2B, and F13A1, were significantly higher in the patients group (3.82±9.6, 6.63±8.45, and 8.9±9.1, respectively) (p < 0.05) compared to those in the control group (1.0±6.0, 1.0±8.1, and 0.6±7.6, respectively). No significant difference in PF4 expression between patients and control group (p = 0.3). Results obtained from enrichment analysis have also supported the above findings. Relative expression levels of these candidate genes could be distinguished between post-acute COVID-19 survivors' pregnant women and control group, significant relative gene expression of ALOX12, ITGA2B, and F13A1 may be associated with an increased risk of placenta-mediated adverse pregnancy outcomes.

References

Ahlberg M, Neovius M, Saltvedt S, Soderling J, Pettersson K, Brandkvist C . Association of SARS-CoV-2 Test Status and Pregnancy Outcomes. JAMA. 2020; 324(17):1782-1785. PMC: 7512127. DOI: 10.1001/jama.2020.19124. View

Alammar H, Nassani R, Alshehri M, Aljohani A, Alrfaei B . Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review. Int J Mol Sci. 2022; 23(1). PMC: 8745694. DOI: 10.3390/ijms23010464. View

Ammash N, Konik E, McBane R, Chen D, Tange J, Grill D . Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation. Arterioscler Thromb Vasc Biol. 2011; 31(11):2760-6. DOI: 10.1161/ATVBAHA.111.232991. View

Baker Jr W, Bick R, Fareed J . Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management. Hematol Oncol Clin North Am. 2008; 22(1):155-74, viii. DOI: 10.1016/j.hoc.2007.10.006. View

Berhan Y . What immunological and hormonal protective factors lower the risk of COVID-19 related deaths in pregnant women?. J Reprod Immunol. 2020; 142:103180. PMC: 7368414. DOI: 10.1016/j.jri.2020.103180. View

Brandt J, Hill J, Reddy A, Schuster M, Patrick H, Rosen T . Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes. Am J Obstet Gynecol. 2020; 224(4):389.e1-389.e9. PMC: 7518835. DOI: 10.1016/j.ajog.2020.09.043. View

Shi L, Li Y, Shi M, Li X, Li G, Cen J . Hsa_circRNA_0008028 Deficiency Ameliorates High Glucose-Induced Proliferation, Calcification, and Autophagy of Vascular Smooth Muscle Cells via miR-182-5p/TRIB3 Axis. Oxid Med Cell Longev. 2022; 2022:5142381. PMC: 9433223. DOI: 10.1155/2022/5142381. View

Cunarro-Lopez Y, Cano-Valderrama O, Pintado-Recarte P, Cueto-Hernandez I, Gonzalez-Garzon B, Garcia-Tizon S . Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result. J Clin Med. 2020; 9(11). PMC: 7694252. DOI: 10.3390/jcm9113552. View

Diaz-Corvillon P, Monckeberg M, Barros A, Illanes S, Soldati A, Nien J . Routine screening for SARS CoV-2 in unselected pregnant women at delivery. PLoS One. 2020; 15(9):e0239887. PMC: 7524006. DOI: 10.1371/journal.pone.0239887. View

10.

Favaloro E . Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia. Int J Lab Hematol. 2021; 43(4):559-570. PMC: 8444734. DOI: 10.1111/ijlh.13629. View

11.

Fenton T, Nasser R, Eliasziw M, Kim J, Bilan D, Sauve R . Validating the weight gain of preterm infants between the reference growth curve of the fetus and the term infant. BMC Pediatr. 2013; 13:92. PMC: 3700759. DOI: 10.1186/1471-2431-13-92. View

12.

Fuentes Carrasco M, Triana A, Cristobal Garcia I, Perez Perez N, Izquierdo Mendez N, Soler Ruiz P . Catastrophic antiphospholipid syndrome during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2021; 264:21-24. PMC: 8260489. DOI: 10.1016/j.ejogrb.2021.07.002. View

13.

Funk W, Wright W . Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor. Proc Natl Acad Sci U S A. 1992; 89(20):9484-8. PMC: 50156. DOI: 10.1073/pnas.89.20.9484. View

14.

Goshua G, Pine A, Meizlish M, Chang C, Zhang H, Bahel P . Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020; 7(8):e575-e582. PMC: 7326446. DOI: 10.1016/S2352-3026(20)30216-7. View

15.

Jafari M, Pormohammad A, Aghayari Sheikh Neshin S, Ghorbani S, Bose D, Alimohammadi S . Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021; 31(5):1-16. PMC: 7883245. DOI: 10.1002/rmv.2208. View

16.

Jain R, Ramaswamy S, Harilal D, Uddin M, Loney T, Nowotny N . Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes. Comput Struct Biotechnol J. 2021; 19:153-160. PMC: 7773686. DOI: 10.1016/j.csbj.2020.12.016. View

17.

Jering K, Claggett B, Cunningham J, Rosenthal N, Vardeny O, Greene M . Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19. JAMA Intern Med. 2021; 181(5):714-717. PMC: 7811188. DOI: 10.1001/jamainternmed.2020.9241. View

18.

Jevtic S, Nazy I . The COVID Complex: A Review of Platelet Activation and Immune Complexes in COVID-19. Front Immunol. 2022; 13:807934. PMC: 8965558. DOI: 10.3389/fimmu.2022.807934. View

19.

Khoury R, Bernstein P, DeBolt C, Stone J, Sutton D, Simpson L . Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers. Obstet Gynecol. 2020; 136(2):273-282. DOI: 10.1097/AOG.0000000000004025. View

20.

Knight V . US election: How covid-19 pushed doctors into the political arena like never before. BMJ. 2020; 371:m4118. DOI: 10.1136/bmj.m4118. View